10x Charak Pharma Femiforte Tablet (Manages excessive vaginal discharge) – 300 Tab

Sale!

10x Charak Pharma Femiforte Tablet (Manages excessive vaginal discharge) – 300 Tab

36.79

Item specifics
Condition:
New: A brand-new, unused, unopened, undamaged item (including handmade items). See the seller?s listing for full details. See all condition definitions Country/Region of Manufacture: India
Brand: Charak Pharma
Formulation: Tablets,
Qty: 10 x 30Tab: 300Tab Type: Herbs

100 in stock

Compare
SKU: CHRKin192

Share this product

10x Charak Pharma Femiforte Tablet (Manages excessive vaginal discharge) – 300 Tab

. . . . Free Shipping . . . .
Normally, vaginal discharge is clear or white. A change in the colour or amount of discharge, along with other symptoms like burning, itching and malodour, may indicate of an infection. Malnutrition, poor hygiene further impairs host response, increasing susceptibility to vaginal infection and inflammation leading excessive vaginal discharge. FEMIFORTE contains potent astringents like Ashoka (Saraca indica) and Lodhra (Symplocos racemosa) which arrest excessive vaginal discharge.

Tanduliya mool (Amaranthus spinosus), Daruharidra (Berberis aristata), Guduchi (Tinospora cordifolia) exerts anti-microbial and anti-inflammatory actions and hence, FEMIFORTE helps in the management of leucorrhoea(white discharge) and vaginitis and minimizes its recurrence.

Key Benefits

? Helps to relieve vaginal itching and burning sensation
? Helps to reduce vaginal discharge and odour
? Helps to maintain health of vaginal tissue

How to Use

? Read the label carefully before use

1-2 tablets twice daily or as advised by the physician

*The information on this page is not intended to be a substitute for professional medical advice. Do not use this information to diagnose or treat your problem without consulting your doctor.

Reviews

There are no reviews yet.

Be the first to review “10x Charak Pharma Femiforte Tablet (Manages excessive vaginal discharge) – 300 Tab”

Your email address will not be published. Required fields are marked *